Sequential chemotherapy and radiotherapy for organ preservation in advanced resectable nonlaryngeal head and neck cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 22, Issue 4, 1999, Pages 403-407

  Khan, Amir ^a   Spiro, Jeffrey D ^a   Dowsett, Robert ^a   Greenberg, Bernard R ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Chemotherapy; Head and neck cancer; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; FLUOROURACIL; METHOTREXATE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNX; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 0033502942     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199908000-00017     Document Type: Article

References (19)

1. Veterans Affairs Laryngeal Cancer Study Group V. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324:1685-9.
2. Karp DO, Vaughan CW, Carter R. et al. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer: a long term follow-up report. Am J Clin Oncol 1991;14:273-9.
3. Shirinian MH, Weber RS, Lippman SM, et al. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer. The M.D. Anderson Cancer Center experience. Head Neck 1994;16:39-44.
4. Urba SG, Forastiere AA, Wolf GT. et al. Intensive induction chemotherapy and radiation for organ preservation in patients with advanced resectable head and neck carcinoma. J Clin Oncol 1994;12:946-53.
5. Clayman GL, Weber RS, Guillamondegui O, et al. Laryngeal preservation for advanced laryngeal and hypopharyngeal cancers. Arch Otolaryngol Head Neck Surg 1995;121:219-23.
6. Pfister DG, Strong EW, Harrison LB, et al. Larynx preservation with combined chemotherapy and radiation therapy in advanced but resectable head and neck cancer. J Clin Oncol 1991;9:850-9.
7. Pfister DG, Harrison LB, Strong EW, et al. Organ-function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation. J Clin Oncol 1995;13:671-80.
8. Kraus DH, Pfister DG, Harrison LB, et al. Laryngeal preservation with combined chemotherapy and radiation therapy in advanced hypopharynx cancer. Otolaryngol Head Neck Surg 1994;111:31-7.
9. Lefebvre J, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 1996;88:890-8.
10. Spiro JD. Preoperative radiotherapy and postoperative pharyngocutaneous fistula: implications for organ preservation in the treatment of laryngeal and hypopharyngeal cancer [poster]. Presented at the American Radium Society Annual Meeting, May 2, 1997.
11. Wei WI, Lam KH. Pharyngocutaneous fistula complicating total laryngectomy. Aust N Z J Surg 1980;50:366-9.
12. Sarkar S, Mehta SA, Tiwari J, et al. Complications following surgery for cancer of the larynx and pyriform fossa. J Surg Oncol 1990;43:245-9.
13. Mendelsohn MS, Bridger GP. Pharyngocutaneous fistulae following laryngectomy. Aust N Z J Surg 1985;55:177-9.
14. McCombe AW, Jones AS. Radiotherapy and complications of laryngectomy. J Laryngol Otol 1993;107:130-2.
15. Papazoglou G, Doundoulakis G, Terzakis G, Dokianakis G. Pharyngocutaneous fistula after total laryngectomy: incidence cause and treatment. Ann Otol Rhinol Laryngol 1994;103:801-5.
16. Sassler AM, Esclamado RM, Wolf GT. Surgery after organ preservation therapy: analysis of wound complications. Arch Otolaryngol Head Neck Surg 1995;121:162-5.
17. Wolf GT, Hong WK. Induction chemotherapy for organ preservation in advanced laryngeal cancer: is there a role? Head Neck 1995;17:279-83.
18. Bradford CR, Poore J, Wilson M, et al. Biological markers which predict response to chemotherapy in head and neck cancer [abstract]. Head Neck 1994;16:509.
19. Los G, Barton R, Vicario D, et al. Molecular markers of tumor response in head and neck carcinoma [abstract]. Head Neck 1994; 16:509.